Successful long-term use of imatinib mesylate in pediatric patients with sclerodermatous chronic GVHD.
Hyery
H
Kim
Nam Hee
NH
Kim
Hyoung Jin
HJ
Kang
Ji Won
JW
Lee
Min Sun
MS
Kim
Kyung Duk
KD
Park
Hee Young
HY
Shin
Hyo Seop
HS
Ahn
D000293:Adolescent; D001549:Benzamides; D002908:Chronic Disease; D003404:Creatinine / Q000032:analysis; D004334:Drug Administration Schedule; D005260:Female; D006086:Graft vs Host Disease / Q000188:drug therapy*; D006801:Humans; D000068877:Imatinib Mesylate; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use*; D011743:Pyrimidines / Q000494:pharmacology / Q000627:therapeutic use*; D012595:Scleroderma, Systemic / Q000188:drug therapy*; D013997:Time Factors; D016896:Treatment Outcome
D001549:Benzamides; D007166:Immunosuppressive Agents; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D003404:Creatinine